CJC-1295 With DAC.
About CJC-1295 With DAC
CJC-1295 With DAC is among the peptides researched in the context of the growth hormone (GH) axis. Albumin conjugation via the DAC extends plasma residence from minutes (native GHRH) to 6-8 days. A single dose can elevate GH/IGF-1 for up to two weeks, in contrast to the pulsatile pattern produced by short-acting GHRH analogs.
Research Application
Used to study sustained, non-pulsatile GHRH-receptor stimulation versus the pulsatile pattern of native GHRH or short-acting analogs such as CJC-1295 without DAC.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
Numerous preclinical and some clinical studies exist on the GH axis, with evidentiary strength varying by substance.
- Teichman SL, et al. J Clin Endocrinol Metab. 2006;91(3):799–805. PMID 16352683
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Similar Peptides
Question about CJC-1295 With DAC?
We reply personally – via email or Telegram.